Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masahiko Yoneta is active.

Publication


Featured researches published by Masahiko Yoneta.


Bioorganic & Medicinal Chemistry Letters | 1995

Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activity

Tetsuro Fujita; Masahiko Yoneta; Ryoji Hirose; Shigeo Sasaki; Kenichiro Inoue; Masatoshi Kiuchi; Susumu Hirase; Kunitomo Adachi; Masafumi Arita; Kenji Chiba

Abstract ISP-I (myriocin, thermozymocidin) was structurally simplified to give 2-amino-2-alkyl-1,3-propanediols that were also potent immunosuppressants. Among the series, 2-amino-2-pentadecyl-1,3-propanediol most actively prolonged rat skin allograft survival and was more effective than ciclosporin.


Bioorganic & Medicinal Chemistry Letters | 1995

2-SUBSTITUTED 2-AMINOETHANOL: MINIMUM ESSENTIAL STRUCTURE FOR IMMUNOSUPPRESSIVE ACTIVITY OF ISP-I (MYRIOCIN)

Tetsuro Fujita; Ryoji Hirose; Norimitsu Hamamichi; Yuuki Kitao; Shigeo Sasaki; Masahiko Yoneta; Kenji Chiba

Abstract 2-Substituted 2-aminoethanol was shown to be the minimum essential structure for the immunosuppressive activity of ISP-i (myriocin, thermozymocidin) by simplification of 2-substituted 2-amino-1,3-propanediol, which was generated by modification of ISP-I. Among the series, 2-amino-4-(4-octylphenyl)butanol hydrochloride displayed comparably potent activity to 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol hydrochloride, FTY720.


Archive | 1993

2-amino-1,3-propanediol compound and immunosuppressant

Tetsuro Fujita; Shigeo Kobe-shi Sasaki; Masahiko Yoneta; Tadashi Mishina; Kunitomo Adachi; Kenji Yoshitomi Pharmac. Ind. Ltd Chiba


Journal of Medicinal Chemistry | 1996

Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols

Tetsuro Fujita; Ryoji Hirose; Masahiko Yoneta; Shigeo Sasaki; Kenichiro Inoue; Masatoshi Kiuchi; Susumu Hirase; Kenji Chiba; Hiroshi Sakamoto; Masafumi Arita


The Journal of Antibiotics | 1996

Determination of Absolute Configuration and Biological Activity of New Immunosuppressants, Mycestericins D, E, F and G

Tetsuro Fujita; Norimitsu Hamamichi; Masatoshi Kiuchi; Tohru Matsuzaki; Yuki Kitao; Kenichiro Inoue; Ryoji Hirose; Masahiko Yoneta; Shigeo Sasaki; Kenji Chba


Archive | 1999

Process for preparing 2-amino malonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for preparing the same

Susumu Hirase; Shigeo Sasaki; Masahiko Yoneta; Ryoji Hirose; Tetsuro Fujita


Archive | 1998

Processes for producing 2-aminomalonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for producing the derivatives

Susumu Hirase; Shigeo Sasaki; Masahiko Yoneta; Ryoji Hirose; Tetsuro Fujita


Archive | 1998

A process for preparing 2-aminomalonic acid derivatives

Tetsuro Fujita; Susumu Hirase; Ryoji Hirose; Shigeo Sasaki; Masahiko Yoneta


Archive | 1997

Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process

Susumu Hirase; Shigeo Sasaki; Masahiko Yoneta; Ryoji Hirose; Tetsuro Fujita


Archive | 2004

PROCESSO PARA A PREPARACAO DE DERIVADOS DE ACIDO 2-AMINOMALONICO

Fujita Tetsuro; Susumu Hirase; Shigeo Sasaki; Masahiko Yoneta; Ryoji Hirose

Collaboration


Dive into the Masahiko Yoneta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenji Chiba

Mitsubishi Tanabe Pharma

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge